StockNews.com began coverage on shares of China Pharma (NYSE:CPHI – Free Report) in a report released on Monday. The firm issued a hold rating on the stock.
China Pharma Price Performance
NYSE:CPHI opened at $0.25 on Monday. The business has a fifty day simple moving average of $0.22 and a two-hundred day simple moving average of $0.26. The company has a debt-to-equity ratio of 0.19, a current ratio of 0.84 and a quick ratio of 0.24. China Pharma has a 1 year low of $0.17 and a 1 year high of $1.16.
China Pharma (NYSE:CPHI – Get Free Report) last announced its quarterly earnings data on Wednesday, August 14th. The company reported ($0.09) earnings per share for the quarter. The firm had revenue of $0.93 million during the quarter. China Pharma had a negative return on equity of 60.19% and a negative net margin of 70.47%.
China Pharma Company Profile
China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People's Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.
See Also
- Five stocks we like better than China Pharma
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- Why Meta’s Pre-Earnings Dip Could Be A Golden Entry Opportunity
- What is the Nikkei 225 index?
- Spirit Airlines Stock Nearly Doubled: Are Clear Skies Ahead?
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- Tesla Stock: Buy the Dips, Sell the Rips
Receive News & Ratings for China Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Pharma and related companies with MarketBeat.com's FREE daily email newsletter.